Global Gastrointestinal Market 2021 by Key Countries, Companies, Type and Application

  • receipt Report ID : 48957
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Gastrointestinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gastrointestinal size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gastrointestinal market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Gastrointestinal market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Esophagus Diseases Drug

Stomach Trouble Drug

Colon Disease Drug

Small Intestinal Diseases Drug

Liver Disease Drug

Pancreatic Disease Drug

Gallbladder Disease Drug

Other

Market segment by Application, can be divided into

Pharmaceutical And Biotechnology Companies

Hospital

Pharmacy

Outpatient Surgical Centers And Clinics

Academic And Research Organizations

Other

Market segment by players, this report covers

Zhejiang Asia-pacific Pharmaceutical

Yangtze Pharmaceutical Group

Tillotts Pharma

Solvay

Shire Pharmaceuticals

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Shandong Luoxin Pharmaceutical Group

Sanofi

Roche

Qilu Pharmaceutical Group

Pfizer

Nycomed (Takeda)

Novartis

Merck

Livzon Pharmaceutical Group

Johnson & Johnson

Jiangsu Aosaikang Pharmaceutical

Inner Mongolia Shuangqi Pharmaceutic

Huadong Medicine

GlaxoSmithKline

Eli Lilly

CTTQ

CSPC

Chengdu Tiantaishan Pharmaceutical

Beijing Kaiyin Technology

AstraZeneca

Amgen

Allergan

AbbVie

Abbott

Fresenius

Daewoong

Dr.Falk Pharma

Minophagen Pharmaceutical

Market segment by Region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, Spain, Benelux, Nordic, and Rest of Europe)

Asia (China, Japan, Korea, India, Southeast Asia, Australia, China Taiwan, and Rest of Asia)

South America (Brazil, Argentina, and Rest of South America)

MENA (Saudi Arabia, UAE, Turkey, and Rest of EMNA)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Gastrointestinal

1.2 Classification of Gastrointestinal by Type

1.2.1 Overview: Global Gastrointestinal Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Gastrointestinal Revenue Market Share by Type in 2020

1.2.3 Esophagus Diseases Drug

1.2.4 Stomach Trouble Drug

1.2.5 Colon Disease Drug

1.2.6 Small Intestinal Diseases Drug

1.2.7 Liver Disease Drug

1.2.8 Pancreatic Disease Drug

1.2.9 Gallbladder Disease Drug

1.2.10 Other

1.3 Global Gastrointestinal Market by Application

1.3.1 Overview: Global Gastrointestinal Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical And Biotechnology Companies

1.3.3 Hospital

1.3.4 Pharmacy

1.3.5 Outpatient Surgical Centers And Clinics

1.3.6 Academic And Research Organizations

1.3.7 Other

1.4 Global Gastrointestinal Market Size & Forecast

1.5 Global Gastrointestinal Market Size and Forecast by Region

1.5.1 Global Gastrointestinal Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Gastrointestinal Market Size by Region, (2016-2026)

1.5.3 North America Gastrointestinal Market Size and Prospect (2016-2026)

1.5.4 Europe Gastrointestinal Market Size and Prospect (2016-2026)

1.5.5 Asia Gastrointestinal Market Size and Prospect (2016-2026)

1.5.6 South America Gastrointestinal Market Size and Prospect (2016-2026)

1.5.7 MENA Gastrointestinal Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Gastrointestinal Market Drivers

1.6.2 Gastrointestinal Market Restraints

1.6.3 Gastrointestinal Trends Analysis

2 Company Profiles

2.1 Zhejiang Asia-pacific Pharmaceutical

2.1.1 Zhejiang Asia-pacific Pharmaceutical Details

2.1.2 Zhejiang Asia-pacific Pharmaceutical Major Business

2.1.3 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product and Solutions

2.1.4 Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Zhejiang Asia-pacific Pharmaceutical Recent Developments and Future Plans

2.2 Yangtze Pharmaceutical Group

2.2.1 Yangtze Pharmaceutical Group Details

2.2.2 Yangtze Pharmaceutical Group Major Business

2.2.3 Yangtze Pharmaceutical Group Gastrointestinal Product and Solutions

2.2.4 Yangtze Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Yangtze Pharmaceutical Group Recent Developments and Future Plans

2.3 Tillotts Pharma

2.3.1 Tillotts Pharma Details

2.3.2 Tillotts Pharma Major Business

2.3.3 Tillotts Pharma Gastrointestinal Product and Solutions

2.3.4 Tillotts Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Tillotts Pharma Recent Developments and Future Plans

2.4 Solvay

2.4.1 Solvay Details

2.4.2 Solvay Major Business

2.4.3 Solvay Gastrointestinal Product and Solutions

2.4.4 Solvay Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Solvay Recent Developments and Future Plans

2.5 Shire Pharmaceuticals

2.5.1 Shire Pharmaceuticals Details

2.5.2 Shire Pharmaceuticals Major Business

2.5.3 Shire Pharmaceuticals Gastrointestinal Product and Solutions

2.5.4 Shire Pharmaceuticals Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Shire Pharmaceuticals Recent Developments and Future Plans

2.6 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

2.6.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Details

2.6.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Major Business

2.6.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product and Solutions

2.6.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments and Future Plans

2.7 Shandong Luoxin Pharmaceutical Group

2.7.1 Shandong Luoxin Pharmaceutical Group Details

2.7.2 Shandong Luoxin Pharmaceutical Group Major Business

2.7.3 Shandong Luoxin Pharmaceutical Group Gastrointestinal Product and Solutions

2.7.4 Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Shandong Luoxin Pharmaceutical Group Recent Developments and Future Plans

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Gastrointestinal Product and Solutions

2.8.4 Sanofi Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Sanofi Recent Developments and Future Plans

2.9 Roche

2.9.1 Roche Details

2.9.2 Roche Major Business

2.9.3 Roche Gastrointestinal Product and Solutions

2.9.4 Roche Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Roche Recent Developments and Future Plans

2.10 Qilu Pharmaceutical Group

2.10.1 Qilu Pharmaceutical Group Details

2.10.2 Qilu Pharmaceutical Group Major Business

2.10.3 Qilu Pharmaceutical Group Gastrointestinal Product and Solutions

2.10.4 Qilu Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Qilu Pharmaceutical Group Recent Developments and Future Plans

2.11 Pfizer

2.11.1 Pfizer Details

2.11.2 Pfizer Major Business

2.11.3 Pfizer Gastrointestinal Product and Solutions

2.11.4 Pfizer Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pfizer Recent Developments and Future Plans

2.12 Nycomed (Takeda)

2.12.1 Nycomed (Takeda) Details

2.12.2 Nycomed (Takeda) Major Business

2.12.3 Nycomed (Takeda) Gastrointestinal Product and Solutions

2.12.4 Nycomed (Takeda) Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Nycomed (Takeda) Recent Developments and Future Plans

2.13 Novartis

2.13.1 Novartis Details

2.13.2 Novartis Major Business

2.13.3 Novartis Gastrointestinal Product and Solutions

2.13.4 Novartis Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Novartis Recent Developments and Future Plans

2.14 Merck

2.14.1 Merck Details

2.14.2 Merck Major Business

2.14.3 Merck Gastrointestinal Product and Solutions

2.14.4 Merck Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Merck Recent Developments and Future Plans

2.15 Livzon Pharmaceutical Group

2.15.1 Livzon Pharmaceutical Group Details

2.15.2 Livzon Pharmaceutical Group Major Business

2.15.3 Livzon Pharmaceutical Group Gastrointestinal Product and Solutions

2.15.4 Livzon Pharmaceutical Group Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Livzon Pharmaceutical Group Recent Developments and Future Plans

2.16 Johnson & Johnson

2.16.1 Johnson & Johnson Details

2.16.2 Johnson & Johnson Major Business

2.16.3 Johnson & Johnson Gastrointestinal Product and Solutions

2.16.4 Johnson & Johnson Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Johnson & Johnson Recent Developments and Future Plans

2.17 Jiangsu Aosaikang Pharmaceutical

2.17.1 Jiangsu Aosaikang Pharmaceutical Details

2.17.2 Jiangsu Aosaikang Pharmaceutical Major Business

2.17.3 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product and Solutions

2.17.4 Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans

2.18 Inner Mongolia Shuangqi Pharmaceutic

2.18.1 Inner Mongolia Shuangqi Pharmaceutic Details

2.18.2 Inner Mongolia Shuangqi Pharmaceutic Major Business

2.18.3 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product and Solutions

2.18.4 Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Inner Mongolia Shuangqi Pharmaceutic Recent Developments and Future Plans

2.19 Huadong Medicine

2.19.1 Huadong Medicine Details

2.19.2 Huadong Medicine Major Business

2.19.3 Huadong Medicine Gastrointestinal Product and Solutions

2.19.4 Huadong Medicine Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Huadong Medicine Recent Developments and Future Plans

2.20 GlaxoSmithKline

2.20.1 GlaxoSmithKline Details

2.20.2 GlaxoSmithKline Major Business

2.20.3 GlaxoSmithKline Gastrointestinal Product and Solutions

2.20.4 GlaxoSmithKline Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 GlaxoSmithKline Recent Developments and Future Plans

2.21 Eli Lilly

2.21.1 Eli Lilly Details

2.21.2 Eli Lilly Major Business

2.21.3 Eli Lilly Gastrointestinal Product and Solutions

2.21.4 Eli Lilly Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Eli Lilly Recent Developments and Future Plans

2.22 CTTQ

2.22.1 CTTQ Details

2.22.2 CTTQ Major Business

2.22.3 CTTQ Gastrointestinal Product and Solutions

2.22.4 CTTQ Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 CTTQ Recent Developments and Future Plans

2.23 CSPC

2.23.1 CSPC Details

2.23.2 CSPC Major Business

2.23.3 CSPC Gastrointestinal Product and Solutions

2.23.4 CSPC Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 CSPC Recent Developments and Future Plans

2.24 Chengdu Tiantaishan Pharmaceutical

2.24.1 Chengdu Tiantaishan Pharmaceutical Details

2.24.2 Chengdu Tiantaishan Pharmaceutical Major Business

2.24.3 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product and Solutions

2.24.4 Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.24.5 Chengdu Tiantaishan Pharmaceutical Recent Developments and Future Plans

2.25 Beijing Kaiyin Technology

2.25.1 Beijing Kaiyin Technology Details

2.25.2 Beijing Kaiyin Technology Major Business

2.25.3 Beijing Kaiyin Technology Gastrointestinal Product and Solutions

2.25.4 Beijing Kaiyin Technology Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.25.5 Beijing Kaiyin Technology Recent Developments and Future Plans

2.26 AstraZeneca

2.26.1 AstraZeneca Details

2.26.2 AstraZeneca Major Business

2.26.3 AstraZeneca Gastrointestinal Product and Solutions

2.26.4 AstraZeneca Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.26.5 AstraZeneca Recent Developments and Future Plans

2.27 Amgen

2.27.1 Amgen Details

2.27.2 Amgen Major Business

2.27.3 Amgen Gastrointestinal Product and Solutions

2.27.4 Amgen Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.27.5 Amgen Recent Developments and Future Plans

2.28 Allergan

2.28.1 Allergan Details

2.28.2 Allergan Major Business

2.28.3 Allergan Gastrointestinal Product and Solutions

2.28.4 Allergan Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.28.5 Allergan Recent Developments and Future Plans

2.29 AbbVie

2.29.1 AbbVie Details

2.29.2 AbbVie Major Business

2.29.3 AbbVie Gastrointestinal Product and Solutions

2.29.4 AbbVie Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.29.5 AbbVie Recent Developments and Future Plans

2.30 Abbott

2.30.1 Abbott Details

2.30.2 Abbott Major Business

2.30.3 Abbott Gastrointestinal Product and Solutions

2.30.4 Abbott Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.30.5 Abbott Recent Developments and Future Plans

2.31 Fresenius

2.31.1 Fresenius Details

2.31.2 Fresenius Major Business

2.31.3 Fresenius Gastrointestinal Product and Solutions

2.31.4 Fresenius Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.31.5 Fresenius Recent Developments and Future Plans

2.32 Daewoong

2.32.1 Daewoong Details

2.32.2 Daewoong Major Business

2.32.3 Daewoong Gastrointestinal Product and Solutions

2.32.4 Daewoong Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.32.5 Daewoong Recent Developments and Future Plans

2.33 Dr.Falk Pharma

2.33.1 Dr.Falk Pharma Details

2.33.2 Dr.Falk Pharma Major Business

2.33.3 Dr.Falk Pharma Gastrointestinal Product and Solutions

2.33.4 Dr.Falk Pharma Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.33.5 Dr.Falk Pharma Recent Developments and Future Plans

2.34 Minophagen Pharmaceutical

2.34.1 Minophagen Pharmaceutical Details

2.34.2 Minophagen Pharmaceutical Major Business

2.34.3 Minophagen Pharmaceutical Gastrointestinal Product and Solutions

2.34.4 Minophagen Pharmaceutical Gastrointestinal Revenue, Gross Margin and Market Share (2019-2021)

2.34.5 Minophagen Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Gastrointestinal Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 5 Gastrointestinal Players Market Share

3.2.2 Top 10 Gastrointestinal Players Market Share

3.2.3 Market Competition Trend

3.3 Gastrointestinal Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Gastrointestinal Revenue and Market Share by Type (2016-2021)

4.2 Global Gastrointestinal Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Gastrointestinal Revenue Market Share by Application (2016-2021)

5.2 Gastrointestinal Market Forecast by Application (2021-2026)

6 North America

6.1 North America Gastrointestinal Market Size and Forecast by Country (2016-2026)

6.2 United States

6.2.1 United States Gastrointestinal Estimates and Projections (2016-2026)

6.2.2 United States Gastrointestinal Market Size by Type (2016-2026)

6.2.3 United States Gastrointestinal Market Size by Application (2016-2026)

6.3 Canada

6.3.1 Canada Gastrointestinal Market Size and Forecast (2016-2026)

6.3.2 Canada Gastrointestinal Market Size by Type (2016-2026)

6.3.3 Canada Gastrointestinal Market Size by Application (2016-2026)

6.4 Mexico

6.4.1 Mexico Gastrointestinal Market Size and Forecast (2016-2026)

6.4.2 Mexico Gastrointestinal Market Size by Type (2016-2026)

6.4.3 Mexico Gastrointestinal Market Size by Application (2016-2026)

7 Europe

7.1 Europe Gastrointestinal Market Size and Forecast by Country (2016-2026)

7.2 Germany

7.2.1 Germany Gastrointestinal Market Size and Forecast (2016-2026)

7.2.2 Germany Gastrointestinal Market Size by Type (2016-2026)

7.2.3 Germany Gastrointestinal Market Size by Application (2016-2026)

7.3 France

7.3.1 France Gastrointestinal Market Size and Forecast (2016-2026)

7.3.2 France Gastrointestinal Market Size by Type (2016-2026)

7.3.3 France Gastrointestinal Market Size by Application (2016-2026)

7.4 UK

7.4.1 UK Gastrointestinal Market Size and Forecast (2016-2026)

7.4.2 UK Gastrointestinal Market Size by Type (2016-2026)

7.4.3 UK Gastrointestinal Market Size by Application (2016-2026)

7.5 Russia

7.5.1 Russia Gastrointestinal Market Size and Forecast (2016-2026)

7.5.2 Russia Gastrointestinal Market Size by Type (2016-2026)

7.5.3 Russia Gastrointestinal Market Size by Application (2016-2026)

7.6 Italy

7.6.1 Italy Gastrointestinal Market Size and Forecast (2016-2026)

7.6.2 Italy Gastrointestinal Market Size by Type (2016-2026)

7.6.3 Italy Gastrointestinal Market Size by Application (2016-2026)

7.7 Spain

7.7.1 Spain Gastrointestinal Market Size and Forecast (2016-2026)

7.7.2 Spain Gastrointestinal Market Size by Type (2016-2026)

7.7.3 Spain Gastrointestinal Market Size by Application (2016-2026)

7.8 Benelux

7.8.1 Benelux Gastrointestinal Market Size and Forecast (2016-2026)

7.8.2 Benelux Gastrointestinal Market Size by Type (2016-2026)

7.8.3 Benelux Gastrointestinal Market Size by Application (2016-2026)

7.9 Nordic

7.9.1 Nordic Gastrointestinal Market Size and Forecast (2016-2026)

7.9.2 Nordic Gastrointestinal Market Size by Type (2016-2026)

7.9.3 Nordic Gastrointestinal Market Size by Application (2016-2026)

8 Asia

8.1 Asia Gastrointestinal Market Size and Forecast by Region (2016-2026)

8.2 China

8.2.1 China Gastrointestinal Market Size and Forecast (2016-2026)

8.2.2 China Gastrointestinal Market Size by Type (2016-2026)

8.2.3 China Gastrointestinal Market Size by Application (2016-2026)

8.3 Japan

8.3.1 Japan Gastrointestinal Market Size and Forecast (2016-2026)

8.3.2 Japan Gastrointestinal Market Size by Type (2016-2026)

8.3.3 Japan Gastrointestinal Market Size by Application (2016-2026)

8.4 South Korea

8.4.1 South Korea Gastrointestinal Market Size and Forecast (2016-2026)

8.4.2 South Korea Gastrointestinal Market Size by Type (2016-2026)

8.4.3 South Korea Gastrointestinal Market Size by Application (2016-2026)

8.5 India

8.5.1 India Gastrointestinal Market Size and Forecast (2016-2026)

8.5.2 India Gastrointestinal Market Size by Type (2016-2026)

8.5.3 India Gastrointestinal Market Size by Application (2016-2026)

8.6 Southeast Asia

8.6.1 Southeast Asia Gastrointestinal Market Size and Forecast (2016-2026)

8.6.2 Southeast Asia Gastrointestinal Market Size by Type (2016-2026)

8.6.3 Southeast Asia Gastrointestinal Market Size by Application (2016-2026)

8.7 China Taiwan

8.7.1 China Taiwan Gastrointestinal Market Size and Forecast (2016-2026)

8.7.2 China Taiwan Gastrointestinal Market Size by Type (2016-2026)

8.7.3 China Taiwan Gastrointestinal Market Size by Application (2016-2026)

8.8 Australia

8.8.1 Australia Gastrointestinal Market Size and Forecast (2016-2026)

8.8.2 Australia Gastrointestinal Market Size by Type (2016-2026)

8.8.3 Australia Gastrointestinal Market Size by Application (2016-2026)

9 South America

9.1 South America Gastrointestinal Market Size and Forecast by Country (2016-2026)

9.2 Brazil

9.2.1 Brazil Gastrointestinal Market Size and Forecast (2016-2026)

9.2.2 Brazil Gastrointestinal Market Size by Type (2016-2026)

9.2.3 Brazil Gastrointestinal Market Size by Application (2016-2026)

9.3 Argentina

9.3.1 Argentina Gastrointestinal Market Size and Forecast (2016-2026)

9.3.2 Argentina Gastrointestinal Market Size by Type (2016-2026)

9.3.3 Argentina Gastrointestinal Market Size by Application (2016-2026)

10 MENA

10.1 MENA Gastrointestinal Market Size and Forecast by Region (2016-2026)

10.2 Saudi Arabia

10.2.1 Saudi Arabia Gastrointestinal Market Size and Forecast (2016-2026)

10.2.2 Saudi Arabia Gastrointestinal Market Size by Type (2016-2026)

10.2.3 Saudi Arabia Gastrointestinal Market Size by Application (2016-2026)

10.3 UAE

10.3.1 UAE Gastrointestinal Market Size and Forecast (2016-2026)

10.3.2 UAE Gastrointestinal Market Size by Type (2016-2026)

10.3.3 UAE Gastrointestinal Market Size by Application (2016-2026)

10.4 Turkey

10.4.1 Turkey Gastrointestinal Market Size and Forecast (2016-2026)

10.4.2 Turkey Gastrointestinal Market Size by Type (2016-2026)

10.4.3 Turkey Gastrointestinal Market Size by Application (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Gastrointestinal Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Gastrointestinal Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Gastrointestinal Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Gastrointestinal Revenue (USD Million) by Region (2016-2021)

Table 5. Global Gastrointestinal Revenue Market Share by Region (2021-2026)

Table 6. Zhejiang Asia-pacific Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 7. Zhejiang Asia-pacific Pharmaceutical Major Business

Table 8. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Product and Solutions

Table 9. Zhejiang Asia-pacific Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Yangtze Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 11. Yangtze Pharmaceutical Group Major Business

Table 12. Yangtze Pharmaceutical Group Gastrointestinal Product and Solutions

Table 13. Yangtze Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Tillotts Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Tillotts Pharma Major Business

Table 16. Tillotts Pharma Gastrointestinal Product and Solutions

Table 17. Tillotts Pharma Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Solvay Corporate Information, Head Office, and Major Competitors

Table 19. Solvay Major Business

Table 20. Solvay Gastrointestinal Product and Solutions

Table 21. Solvay Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Shire Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Shire Pharmaceuticals Major Business

Table 24. Shire Pharmaceuticals Gastrointestinal Product and Solutions

Table 25. Shire Pharmaceuticals Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Corporate Information, Head Office, and Major Competitors

Table 27. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Major Business

Table 28. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Product and Solutions

Table 29. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Shandong Luoxin Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 31. Shandong Luoxin Pharmaceutical Group Major Business

Table 32. Shandong Luoxin Pharmaceutical Group Gastrointestinal Product and Solutions

Table 33. Shandong Luoxin Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Sanofi Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi Major Business

Table 36. Sanofi Gastrointestinal Product and Solutions

Table 37. Sanofi Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Roche Corporate Information, Head Office, and Major Competitors

Table 39. Roche Major Business

Table 40. Roche Gastrointestinal Product and Solutions

Table 41. Roche Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Qilu Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 43. Qilu Pharmaceutical Group Major Business

Table 44. Qilu Pharmaceutical Group Gastrointestinal Product and Solutions

Table 45. Qilu Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pfizer Corporate Information, Head Office, and Major Competitors

Table 47. Pfizer Major Business

Table 48. Pfizer Gastrointestinal Product and Solutions

Table 49. Pfizer Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Nycomed (Takeda) Corporate Information, Head Office, and Major Competitors

Table 51. Nycomed (Takeda) Major Business

Table 52. Nycomed (Takeda) Gastrointestinal Product and Solutions

Table 53. Nycomed (Takeda) Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Novartis Corporate Information, Head Office, and Major Competitors

Table 55. Novartis Major Business

Table 56. Novartis Gastrointestinal Product and Solutions

Table 57. Novartis Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Merck Corporate Information, Head Office, and Major Competitors

Table 59. Merck Major Business

Table 60. Merck Gastrointestinal Product and Solutions

Table 61. Merck Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Livzon Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 63. Livzon Pharmaceutical Group Major Business

Table 64. Livzon Pharmaceutical Group Gastrointestinal Product and Solutions

Table 65. Livzon Pharmaceutical Group Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 67. Johnson & Johnson Major Business

Table 68. Johnson & Johnson Gastrointestinal Product and Solutions

Table 69. Johnson & Johnson Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Jiangsu Aosaikang Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 71. Jiangsu Aosaikang Pharmaceutical Major Business

Table 72. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Product and Solutions

Table 73. Jiangsu Aosaikang Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Inner Mongolia Shuangqi Pharmaceutic Corporate Information, Head Office, and Major Competitors

Table 75. Inner Mongolia Shuangqi Pharmaceutic Major Business

Table 76. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Product and Solutions

Table 77. Inner Mongolia Shuangqi Pharmaceutic Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Huadong Medicine Corporate Information, Head Office, and Major Competitors

Table 79. Huadong Medicine Major Business

Table 80. Huadong Medicine Gastrointestinal Product and Solutions

Table 81. Huadong Medicine Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 83. GlaxoSmithKline Major Business

Table 84. GlaxoSmithKline Gastrointestinal Product and Solutions

Table 85. GlaxoSmithKline Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 87. Eli Lilly Major Business

Table 88. Eli Lilly Gastrointestinal Product and Solutions

Table 89. Eli Lilly Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. CTTQ Corporate Information, Head Office, and Major Competitors

Table 91. CTTQ Major Business

Table 92. CTTQ Gastrointestinal Product and Solutions

Table 93. CTTQ Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. CSPC Corporate Information, Head Office, and Major Competitors

Table 95. CSPC Major Business

Table 96. CSPC Gastrointestinal Product and Solutions

Table 97. CSPC Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Chengdu Tiantaishan Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 99. Chengdu Tiantaishan Pharmaceutical Major Business

Table 100. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Product and Solutions

Table 101. Chengdu Tiantaishan Pharmaceutical Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 102. Beijing Kaiyin Technology Corporate Information, Head Office, and Major Competitors

Table 103. Beijing Kaiyin Technology Major Business

Table 104. Beijing Kaiyin Technology Gastrointestinal Product and Solutions

Table 105. Beijing Kaiyin Technology Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 106. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 107. AstraZeneca Major Business

Table 108. AstraZeneca Gastrointestinal Product and Solutions

Table 109. AstraZeneca Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 110. Amgen Corporate Information, Head Office, and Major Competitors

Table 111. Amgen Major Business

Table 112. Amgen Gastrointestinal Product and Solutions

Table 113. Amgen Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 114. Allergan Corporate Information, Head Office, and Major Competitors

Table 115. Allergan Major Business

Table 116. Allergan Gastrointestinal Product and Solutions

Table 117. Allergan Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 118. AbbVie Corporate Information, Head Office, and Major Competitors

Table 119. AbbVie Major Business

Table 120. AbbVie Gastrointestinal Product and Solutions

Table 121. AbbVie Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 122. Abbott Corporate Information, Head Office, and Major Competitors

Table 123. Abbott Major Business

Table 124. Abbott Gastrointestinal Product and Solutions

Table 125. Abbott Gastrointestinal Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 126. Global Gastrointestinal Revenue (USD Million) by Players (2019-2021)

Table 127. Global Gastrointestinal Revenue Share by Players (2019-2021)

Table 128. Breakdown of Gastrointestinal by Company Type (Tier 1, Tier 2 and Tier 3)

Table 129. Gastrointestinal Players Head Office, Products and Services Provided

Table 130. Gastrointestinal Mergers & Acquisitions in the Past Five Years

Table 131. Gastrointestinal New Entrants and Expansion Plans

Table 132. Global Gastrointestinal Revenue (USD Million) by Type (2016-2021)

Table 133. Global Gastrointestinal Revenue Share by Type (2016-2021)

Table 134. Global Gastrointestinal Revenue Forecast by Type (2021-2026)

Table 135. Global Gastrointestinal Revenue by Application (2016-2021)

Table 136. Global Gastrointestinal Revenue Forecast by Application (2021-2026)

Table 137. North America Gastrointestinal Revenue (USD Million) by Country (2016-2026)

Table 138. North America Gastrointestinal Market Share by Country (2016-2026)

Table 139. United States Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 140. United States Gastrointestinal Market Share by Type (2016-2026)

Table 141. United States Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 142. United States Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 143. Canada Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 144. Canada Gastrointestinal Market Share by Type (2016-2026)

Table 145. Canada Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 146. Canada Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 147. Mexico Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 148. Mexico Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 149. Mexico Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 150. Mexico Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 151. Europe Gastrointestinal Revenue (USD Million) by Country (2016-2026)

Table 152. Europe Gastrointestinal Market Share by Country (2016-2026)

Table 153. Germany Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 154. Germany Gastrointestinal Market Share by Type (2016-2026)

Table 155. Germany Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 156. Germany Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 157. France Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 158. France Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 159. France Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 160. France Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 161. UK Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 162. UK Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 163. UK Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 164. UK Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 165. Russia Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 166. Russia Gastrointestinal Market Share by Type (2016-2026)

Table 167. Russia Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 168. Russia Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 169. Italy Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 170. Italy Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 171. Italy Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 172. Italy Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 173. Spain Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 174. Spain Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 175. Spain Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 176. Spain Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 177. Benelux Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 178. Benelux Gastrointestinal Market Share by Type (2016-2026)

Table 179. Benelux Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 180. Benelux Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 181. Nordic Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 182. Nordic Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 183. Nordic Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 184. Nordic Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 185. Asia Gastrointestinal Revenue (USD Million) by Region (2016-2026)

Table 186. Asia Gastrointestinal Market Share by Region (2016-2026)

Table 187. China Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 188. China Gastrointestinal Market Share by Type (2016-2026)

Table 189. China Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 190. China Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 191. Japan Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 192. Japan Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 193. Japan Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 194. Japan Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 195. South Korea Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 196. South Korea Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 197. South Korea Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 198. South Korea Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 199. India Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 200. India Gastrointestinal Market Share by Type (2016-2026)

Table 201. India Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 202. India Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 203. Southeast Asia Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 204. Southeast Asia Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 205. Southeast Asia Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 206. Southeast Asia Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 207. China Taiwan Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 208. China Taiwan Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 209. China Taiwan Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 210. China Taiwan Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 211. Australia Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 212. Australia Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 213. Australia Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 214. Australia Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 215. South America Gastrointestinal Revenue (USD Million) by Country (2016-2026)

Table 216. South America Gastrointestinal Market Share by Country (2016-2026)

Table 217. Brazil Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 218. Brazil Gastrointestinal Market Share by Type (2016-2026)

Table 219. Brazil Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 220. Brazil Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 221. Argentina Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 222. Argentina Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 223. Argentina Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 224. Argentina Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 225. MENA Gastrointestinal Revenue (USD Million) by Country (2016-2026)

Table 226. MENA Gastrointestinal Market Share by Country (2016-2026)

Table 227. Saudi Arabia Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 228. Saudi Arabia Gastrointestinal Market Share by Type (2016-2026)

Table 229. Saudi Arabia Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 230. Saudi Arabia Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 231. UAE Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 232. UAE Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 233. UAE Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 234. UAE Gastrointestinal Market Share Analysis by Application (2016-2026)

Table 235. Turkey Gastrointestinal Market Growth Prospects (USD Million) by Type (2016-2026)

Table 236. Turkey Gastrointestinal Percentage Share Breakdown by Type (2016-2026)

Table 237. Turkey Gastrointestinal Estimates and Projections (USD Million) by Application for the Period 2016-2026

Table 238. Turkey Gastrointestinal Market Share Analysis by Application (2016-2026)

List of Figures

Figure 1. Gastrointestinal Picture

Figure 2. Global Gastrointestinal Revenue Market Share by Type in 2020

Figure 3. Esophagus Diseases Drug

Figure 4. Stomach Trouble Drug

Figure 5. Colon Disease Drug

Figure 6. Small Intestinal Diseases Drug

Figure 7. Liver Disease Drug

Figure 8. Pancreatic Disease Drug

Figure 9. Gallbladder Disease Drug

Figure 10. Other

Figure 11. Gastrointestinal Revenue Market Share by Application in 2020

Figure 12. Pharmaceutical And Biotechnology Companies Picture

Figure 13. Hospital Picture

Figure 14. Pharmacy Picture

Figure 15. Outpatient Surgical Centers And Clinics Picture

Figure 16. Academic And Research Organizations Picture

Figure 17. Other Picture

Figure 18. Global Gastrointestinal Market Size, (USD Million): 2020 VS 2021 VS 2026

Figure 19. Global Gastrointestinal Revenue and Outlook (2016-2026) & (USD Million)

Figure 20. Global Gastrointestinal Revenue Market Share by Region (2016-2026)

Figure 21. Global Gastrointestinal Revenue Market Share by Region in 2020

Figure 22. North America Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Europe Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Asia Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. South America Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)

Figure 26. MENA Gastrointestinal Revenue (USD Million) and Growth Rate (2016-2026)

Figure 27. Gastrointestinal Market Drivers

Figure 28. Gastrointestinal Market Restraints

Figure 29. Gastrointestinal Market Trends

Figure 30. Zhejiang Asia-pacific Pharmaceutical Recent Developments and Future Plans

Figure 31. Yangtze Pharmaceutical Group Recent Developments and Future Plans

Figure 32. Tillotts Pharma Recent Developments and Future Plans

Figure 33. Solvay Recent Developments and Future Plans

Figure 34. Shire Pharmaceuticals Recent Developments and Future Plans

Figure 35. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Developments and Future Plans

Figure 36. Shandong Luoxin Pharmaceutical Group Recent Developments and Future Plans

Figure 37. Sanofi Recent Developments and Future Plans

Figure 38. Roche Recent Developments and Future Plans

Figure 39. Qilu Pharmaceutical Group Recent Developments and Future Plans

Figure 40. Pfizer Recent Developments and Future Plans

Figure 41. Nycomed (Takeda) Recent Developments and Future Plans

Figure 42. Novartis Recent Developments and Future Plans

Figure 43. Merck Recent Developments and Future Plans

Figure 44. Livzon Pharmaceutical Group Recent Developments and Future Plans

Figure 45. Johnson & Johnson Recent Developments and Future Plans

Figure 46. Jiangsu Aosaikang Pharmaceutical Recent Developments and Future Plans

Figure 47. Inner Mongolia Shuangqi Pharmaceutic Recent Developments and Future Plans

Figure 48. Huadong Medicine Recent Developments and Future Plans

Figure 49. GlaxoSmithKline Recent Developments and Future Plans

Figure 50. Eli Lilly Recent Developments and Future Plans

Figure 51. CTTQ Recent Developments and Future Plans

Figure 52. CSPC Recent Developments and Future Plans

Figure 53. Chengdu Tiantaishan Pharmaceutical Recent Developments and Future Plans

Figure 54. Beijing Kaiyin Technology Recent Developments and Future Plans

Figure 55. AstraZeneca Recent Developments and Future Plans

Figure 56. Amgen Recent Developments and Future Plans

Figure 57. Allergan Recent Developments and Future Plans

Figure 58. AbbVie Recent Developments and Future Plans

Figure 59. Abbott Recent Developments and Future Plans

Figure 60. Fresenius Recent Developments and Future Plans

Figure 61. Daewoong Recent Developments and Future Plans

Figure 62. Dr.Falk Pharma Recent Developments and Future Plans

Figure 63. Minophagen Pharmaceutical Recent Developments and Future Plans

Figure 64. Global Gastrointestinal Revenue Share by Players in 2020

Figure 65. Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 66. Global Top 5 Players Gastrointestinal Revenue Market Share in 2020

Figure 67. Global Top 10 Players Gastrointestinal Revenue Market Share in 2020

Figure 68. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 69. Global Gastrointestinal Revenue Share by Type in 2020

Figure 70. Global Gastrointestinal Market Share Forecast by Type (2021-2026)

Figure 71. Global Gastrointestinal Revenue Share by Application (2016-2021)

Figure 72. Global Gastrointestinal Revenue Share by Application in 2020

Figure 73. Global Gastrointestinal Market Share Forecast by Application (2021-2026)

Figure 74. North America Gastrointestinal Market Share by Country (2016-2026)

Figure 75. United States Gastrointestinal Revenue (USD Million) and Forecast (2016-2026)

Figure 76. Canada Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 77. Gastrointestinal Market in Mexico: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 78. Europe Gastrointestinal Market Share by Country (2016-2026)

Figure 79. Europe Gastrointestinal Market Share by Country in 2020

Figure 80. Germany Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 81. France Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 82. Gastrointestinal Market in UK: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 83. Russia Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 84. Italy Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 85. Gastrointestinal Market in Spain: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 86. Benelux Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 87. Nordic Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 88. Asia Gastrointestinal Market Size Share by Region (2016-2026)

Figure 89. Asia Gastrointestinal Market Size Share by Regions in 2020

Figure 90. China Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 91. Japan Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 92. Gastrointestinal Market in South Korea: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 93. India Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 94. Southeast Asia Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 95. Gastrointestinal Market in China Taiwan: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 96. Gastrointestinal Market in Australia: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 97. South America Gastrointestinal Market Share by Country (2016-2026)

Figure 98. South America Gastrointestinal Market Share by Country in 2020

Figure 99. Brazil Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 100. Argentina Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 101. MENA Gastrointestinal Market Share by Country (2016-2026)

Figure 102. MENA Gastrointestinal Market Size Share by Country in 2020

Figure 103. Saudi Arabia Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 104. UAE Gastrointestinal Estimates and Projections (USD Million) and Forecast (2016-2026)

Figure 105. Gastrointestinal Market in Turkey: Recent Past, Current and Future Analysis (USD Million) and Forecast (2016-2026)

Figure 106. Methodology

Figure 107. Research Process and Data Source